Western Union Officers Sold Near $9.50 as Stock Hit $7.53

NEW YORK, June 12 —

Two Western Union executives sold shares at prices between $9.21 and $9.47 in late April and early May 2026. The stock now trades at $7.54 — roughly 20% below those exit prices. When insiders sell, the stock drops sharply, and back-to-back prospectus supplement filings appear within days, the pattern warrants scrutiny.

The Selling Pattern

Adams made three separate open-market sales on May 1 — 3,184, 4,148, and 12,592 shares, executed at $9.22, $9.21, and $9.23 respectively. That distribution across prices on a single day suggests deliberate execution rather than an automated 10b5-1 sweep at a round lot. Three days earlier, on April 28, Giovanni Angelini — President for Europe, Africa, and MEPA — sold 6,000 shares at $9.47, netting $56,850.

Over the trailing 90-day period, insider activity shows net selling of approximately $0.24 million with zero recorded open-market purchases. No offsetting buys from other insiders soften the picture. The exits were modest in dollar terms, but the absence of any purchase activity on the other side matters when the stock is sitting at a 3.9x forward P/E. If the valuation were obviously compelling to insiders, you'd expect someone to be buying.

The Prospectus Timing

On April 30 and May 1 — the same two-day window when Adams was executing his sales — Western Union filed two 424B5 prospectus supplements with the SEC. A 424B5 is a shelf offering supplement, used when a company draws down on a previously registered securities shelf to raise capital or facilitate a secondary sale. Back-to-back filings on consecutive days is unusual cadence. Whether these filings relate to debt, equity, or some hybrid instrument, the timing alongside insider sales warrants a close look at WU's capital structure. The April 24 earnings 8-K under Items 2.02 and 9.01 preceded all of this by less than a week.

The Value Trap Question

On pure multiples, Western Union looks cheap — genuinely cheap. A 3.9x forward P/E on a $2.35 billion market cap, with $291 million in trailing free cash flow, implies a cash yield that commands income investors' attention. The FCF yield alone, at roughly 12% on market cap, is the kind of number that shows up in deep-value screens.

The problem is the growth line. Trailing twelve-month revenue of $4.05 billion came in at negative 0.1% year-over-year. That's not contraction — it's stagnation. For a company whose core business is cross-border money transfer, standing still while fintech competitors press harder into the remittance corridor is a different kind of risk than an earnings miss. The cheap multiple may be pricing exactly that: a business that generates cash but faces secular pressure on volumes. Deep value and value trap often look identical at the moment of decision.

The Grant Footnote

On June 5, Angelini received two separate grants of 33,423 shares each — reported as RSUs and performance stock units per news reports. The optics here cut both ways. Receiving equity compensation after selling open-market shares is standard executive practice; vesting schedules and performance conditions create different economic exposure than outright ownership. Still, the sequence — sell near $9.47, receive fresh grants when the stock is materially lower — shows how management's incentives are currently structured.

What Comes Next

The next real checkpoint is the subsequent earnings report, which will clarify whether the Q1 results disclosed in the April 24 8-K represent a floor or a continuation of the revenue stagnation trend. On the capital structure side, the purpose and terms of the two 424B5 filings deserve attention — any dilutive equity issuance at current prices would be a significant negative for existing holders.

The analyst consensus price target sits at approximately $9.08, against a current price of $7.54 — a gap of roughly 20%. That consensus was likely set before insiders were selling at exactly those consensus-target levels. The variables that would shift the neutral view toward conviction are a revenue inflection (any return to positive growth), clarity on what those prospectus supplements were financing, and insider buying at current prices. Until at least one of those conditions is met, the value case and the uncertainty case remain in balance.

Run the free The Western Union Company deep-dive → The Western Union Company deep-dive

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Why is Western Union stock trading below $8?

The stock currently trades at $7.535, well below the analyst consensus target of $9.08. Trailing twelve-month revenue growth is flat at negative 0.1%, which limits the re-rating argument even as the company generates $291 million in free cash flow on a $2.35 billion market cap.

Did Western Union insiders sell shares in 2026?

Chief Legal Officer Benjamin Carlton Adams sold 19,924 shares on May 1, 2026 at prices between $9.21 and $9.23, totaling approximately $183,883. Regional President Giovanni Angelini sold 6,000 shares at $9.47 on April 28. Over the trailing 90-day period, no open-market purchases were recorded by any insider.

What does a 424B5 filing mean for investors?

A 424B5 is a prospectus supplement a company files when executing a securities offering from an existing shelf registration. Western Union filed two on consecutive days, April 30 and May 1, overlapping directly with the insider sales window. The filings raise questions about whether the company was issuing equity, debt, or both during that period.

Is Western Union stock undervalued at 3.9x P/E?

At 3.9x forward P/E and $291 million in trailing free cash flow, the numbers look inexpensive on the surface. But flat revenue growth of negative 0.1%, net insider selling of approximately $0.24 million with zero open-market purchases, and back-to-back prospectus supplements introduce enough uncertainty to withhold a clear directional view.

Why did Western Union executives receive RSU grants?

Giovanni Angelini received two separate grants of 33,423 shares each on June 5, reported as RSUs and performance stock units, as part of the standard executive compensation cycle. These scheduled grants operate on a board approval calendar and are distinct from the open-market sales Angelini made weeks earlier at $9.47 per share.